News & Events Join us at ESMO 2025 in Berlin Show details ESMO 2024 in Barcelona Show details STUDY MAY REVOLUTIONISE GLIOMA DIAGNOSIS Show details ESMO 2023 – Dr. Crook presents together with Datar Cancer Genetics Show details Further Breakthrough Device Designation from the FDA – now also for blood test to diagnose inaccessible brain tumours Show details RENOWNED ASSIGNMENT TO THE SCIENTIFIC ADVISORY BOARD OF DATAR CANCER GENETICS Show details PROMISING INITIAL STUDY RESULTS IN THE DETECTION OF GLIAL MALIGNANCIES USING GLIAL CELLS IN THE BLOOD Show details HOT NEWS! OUR LATEST PUBLICATION IN FRONTIERS IN MEDICINE Show details MARKET ENTRY IN THE USA THANKS TO AGREEMENT WITH ARTEMIS DNA Show details Screeening test for the early detection of prostate cancer also receives “Breakthrough Device Designation” from the FDA Show details US FDA grants ‘Breakthrough Designation’ for our blood test used for early detection of breast cancer Show details MKOT – Precision Oncology Symposium Sept. 2021 Show details DCG expands Product Portfolio to Screening-Test Show details Our cooperation with Iylon Precision Oncology Show details
